Stay updated on Upadacitinib vs Placebo in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in RA Clinical Trial page
- Check3 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2 in the page footer.SummaryDifference0.1%

- Check10 days agoChange DetectedRemoved the terms 'Rheumatoid arthritis' and the related topic 'MedlinePlus Genetics' from the page.SummaryDifference0.1%

- Check17 days agoChange DetectedAdded 'Rheumatoid arthritis' as a topic and added 'MedlinePlus Genetics' as a related topic to the page.SummaryDifference0.1%

- Check25 days agoChange DetectedRemoved the Rheumatoid arthritis topic and the related MedlinePlus Genetics topic from the page. This reduces disease-specific context and related topic links on the study page.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision: v3.5.0 was added. Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check39 days agoChange DetectedAdded Rheumatoid arthritis and MedlinePlus Genetics as related topics, and updated the revision from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib vs Placebo in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA Clinical Trial page.